|
NGFRAP1 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.06334949126585E-12 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.72330002782218E-09 |
| Normal-vs-Stage2 |
1.40739997434025E-09 |
| Normal-vs-Stage3 |
9.172200E-02 |
| Normal-vs-Stage4 |
3.50649953517745E-10 |
| Stage1-vs-Stage2 |
2.131400E-01 |
| Stage1-vs-Stage3 |
3.980500E-02 |
| Stage1-vs-Stage4 |
3.000400E-02 |
| Stage2-vs-Stage3 |
1.637550E-02 |
| Stage2-vs-Stage4 |
4.968600E-01 |
| Stage3-vs-Stage4 |
7.221100E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.47709630585291E-11 |
| Normal-vs-AfricanAmerican |
2.22670004657033E-09 |
| Normal-vs-Asian |
4.435900E-02 |
| Caucasian-vs-AfricanAmerican |
9.319600E-01 |
| Caucasian-vs-Asian |
3.967400E-01 |
| AfricanAmerican-vs-Asian |
3.687000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.62458935193399E-12 |
| Normal-vs-Female |
8.18890000000572E-05 |
| Male-vs-Female |
6.05369999999716E-05 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.71080000020008E-07 |
| Normal-vs-Extreme_Weight |
4.9809000257639E-09 |
| Normal-vs-Obese |
6.79229994471342E-09 |
| Normal-vs-Extreme_Obese |
7.60320000000592E-05 |
| Normal_Weight-vs-Extreme_Weight |
1.077960E-01 |
| Normal_Weight-vs-Obese |
6.865800E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.416200E-01 |
| Extreme_Weight-vs-Obese |
1.894810E-01 |
| Extreme_Weight-vs-Extreme_Obese |
8.470000E-01 |
| Obese-vs-Extreme_Obese |
4.246400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.019100E-04 |
| Normal-vs-Age(41-60Yrs) |
1.14770004611131E-09 |
| Normal-vs-Age(61-80Yrs) |
4.91606755304019E-12 |
| Normal-vs-Age(81-100Yrs) |
9.57040000000298E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.775600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.678600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.377000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.421600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.004400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.719000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.57060003786103E-09 |
| Normal-VS-Type2 PRCC |
8.2541000000047E-05 |
| Normal-VS-KIRP CIMP |
1.41459999269955E-09 |
| Normal-VS-Unclassified PRCC |
1.29350000044326E-07 |
| Type1 PRCC-VS-Type2 PRCC |
2.276300E-02 |
| Type1 PRCC-VS-KIRP CIMP |
1.109760E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
3.719400E-01 |
| Type2 PRCC-VS-KIRP CIMP |
3.119400E-03 |
| Type2 PRCC-VS-Unclassified PRCC |
2.242000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
6.983500E-02 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.83450005081443E-09 |
| Normal-vs-N1 |
8.749800E-02 |
| Normal-vs-N2 |
2.471800E-02 |
| N0-vs-N1 |
1.380030E-01 |
| N0-vs-N2 |
8.927800E-01 |
| N1-vs-N2 |
5.680200E-01 |
|
|
